Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

NCT06287593 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06287593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06287593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
Lead sponsor
Zhejiang University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 15, 2024
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

egf-r positive non-small cell lung cancer